Oligodendrocyte progenitor cells' fate after neonatal asphyxia—Puzzling implications for the development of hypoxic–ischemic encephalopathy

Justyna Janowska,Justyna Gargas,Karolina Zajdel,Michal Wieteska,Kamil Lipinski,Malgorzata Ziemka‐Nalecz,Malgorzata Frontczak‐Baniewicz,Joanna Sypecka

DOI: https://doi.org/10.1111/bpa.13255

IF: 7.611

2024-03-21

Brain Pathology

Abstract:This study presents the effect of neonatal hypoxia–ischemia on white matter development. Study was conducted with different imaging techniques on rat model of the injury, providing evidences that oligodendrocyte differentiation or maturation in hypoxic–ischemic brain is affected. Results were supported by studies on an in vitro model using primary rat oligodendrocyte progenitor cells. Premature birth or complications during labor can cause temporary disruption of cerebral blood flow, often followed by long‐term disturbances in brain development called hypoxic–ischemic (HI) encephalopathy. Diffuse damage to the white matter is the most frequently detected pathology in this condition. We hypothesized that oligodendrocyte progenitor cell (OPC) differentiation disturbed by mild neonatal asphyxia may affect the viability, maturation, and physiological functioning of oligodendrocytes. To address this issue, we studied the effect of temporal HI in the in vivo model in P7 rats with magnetic resonance imaging (MRI), microscopy techniques and biochemical analyses. Moreover, we recreated the injury in vitro performing the procedure of oxygen–glucose deprivation on rat neonatal OPCs to determine its effect on cell viability, proliferation, and differentiation. In the in vivo model, MRI evaluation revealed changes in the volume of different brain regions, as well as changes in the directional diffusivity of water in brain tissue that may suggest pathological changes to myelinated neuronal fibers. Hypomyelination was observed in the cortex, striatum, and CA3 region of the hippocampus. Severe changes to myelin ultrastructure were observed, including delamination of myelin sheets. Interestingly, shortly after the injury, an increase in oligodendrocyte proliferation was observed, followed by an overproduction of myelin proteins 4 weeks after HI. Results verified with the in vitro model indicate, that in the first days after damage, OPCs do not show reduced viability, intensively proliferate, and overexpress myelin proteins and oligodendrocyte‐specific transcription factors. In conclusion, despite the increase in oligodendrocyte proliferation and myelin protein expression after HI, the production of functional myelin sheaths in brain tissue is impaired. Presented study provides a detailed description of oligodendrocyte pathophysiology developed in an effect of HI injury, resulting in an altered CNS myelination. The described models may serve as useful tools for searching and testing effective of effective myelination‐supporting therapies for HI injuries.

pathology,neurosciences,clinical neurology